OR4X2
gene geneOn this page
Summary
OR4X2 (olfactory receptor family 4 subfamily X member 2, HGNC:15184) is a protein-coding gene on chromosome 11p11.2, encoding Olfactory receptor 4X2 (Q8NGF9). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. This olfactory receptor gene is a segregating pseudogene, where some individuals have an allele that encodes a functional olfactory receptor, while other individuals have an allele encoding a protein that is predicted to be non-functional.
Source: NCBI Gene 119764 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 86 total
- MANE Select transcript:
NM_001004727
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15184 |
| Approved symbol | OR4X2 |
| Name | olfactory receptor family 4 subfamily X member 2 |
| Location | 11p11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000172208 |
| Ensembl biotype | protein_coding |
| Entrez | 119764 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000624868
RefSeq mRNA: 1 — MANE Select: NM_001004727
NM_001004727
Canonical transcript exons
ENST00000624868 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003989334 | 48245104 | 48246015 |
Expression profiles
Bgee: expression breadth tissue_specific, 1 present calls, max score 48.48.
Top tissues by expression
126 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| granulocyte | CL:0000094 | 48.48 | silver quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| sural nerve | UBERON:0015488 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| bone marrow | UBERON:0002371 | 33.18 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.22 | gold quality |
| liver | UBERON:0002107 | 28.32 | gold quality |
| monocyte | CL:0000576 | 28.30 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| blood | UBERON:0000178 | 27.10 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| urinary bladder | UBERON:0001255 | 27.02 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| muscle of leg | UBERON:0001383 | 25.06 | gold quality |
| calcaneal tendon | UBERON:0003701 | 24.97 | gold quality |
| primary visual cortex | UBERON:0002436 | 24.61 | gold quality |
| pancreas | UBERON:0001264 | 24.48 | gold quality |
| frontal cortex | UBERON:0001870 | 24.28 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.98 |
Regulation
Is transcription factor: no
Cross-species orthologs
10 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or4x11 | ENSMUSG00000059910 |
| mus_musculus | Or4x15 | ENSMUSG00000075064 |
| mus_musculus | Or4x12 | ENSMUSG00000075067 |
| mus_musculus | Or4x13 | ENSMUSG00000082980 |
| mus_musculus | Or4x6 | ENSMUSG00000084336 |
| mus_musculus | Or4x18 | ENSMUSG00000089859 |
| rattus_norvegicus | Or4x13 | ENSRNOG00000075319 |
| rattus_norvegicus | Or4x11c | ENSRNOG00000075781 |
| rattus_norvegicus | Or4x6 | ENSRNOG00000087687 |
| rattus_norvegicus | Or4x11 | ENSRNOG00000091094 |
Paralogs (130): OR1I1 (ENSG00000094661), OR12D3 (ENSG00000112462), OR7A10 (ENSG00000127515), OR7C2 (ENSG00000127529), OR7C1 (ENSG00000127530), OR1E2 (ENSG00000127780), OR1J1 (ENSG00000136834), OR1L4 (ENSG00000136939), OR4D1 (ENSG00000141194), OR4K1 (ENSG00000155249), OR3A3 (ENSG00000159961), OR7G1 (ENSG00000161807), OR1Q1 (ENSG00000165202), OR1K1 (ENSG00000165204), OR4K2 (ENSG00000165762), OR4D6 (ENSG00000166884), OR1F1 (ENSG00000168124), OR4K14 (ENSG00000169484), OR4K15 (ENSG00000169488), OR7G3 (ENSG00000170920), OR7G2 (ENSG00000170923), OR1M1 (ENSG00000170929), OR4D5 (ENSG00000171014), OR1L6 (ENSG00000171459), OR1L3 (ENSG00000171481), OR1L8 (ENSG00000171496), OR1N2 (ENSG00000171501), OR1N1 (ENSG00000171505), OR2AT4 (ENSG00000171561), OR1A1 (ENSG00000172146), OR1A2 (ENSG00000172150), OR4C11 (ENSG00000172188), OR4D9 (ENSG00000172742), OR10K1 (ENSG00000173285), OR1L1 (ENSG00000173679), OR7D4 (ENSG00000174667), OR4S2 (ENSG00000174982), OR4B1 (ENSG00000175619), OR4D11 (ENSG00000176200), OR4K17 (ENSG00000176230)
Protein
Protein identifiers
Olfactory receptor 4X2 — Q8NGF9 (reviewed: Q8NGF9)
Alternative names: Olfactory receptor OR11-105
All UniProt accessions (2): A0A126GVL5, Q8NGF9
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Polymorphism. A stop codon in the gene coding for this protein at position Tyr-27 is responsible for functional diversity thus producing a pseudogene.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_001004727* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
| IPR050427 | Olfactory_Receptors | Family |
Pfam: PF13853
UniProt features (17 total): topological domain 8, transmembrane region 7, chain 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NGF9-F1 | 85.13 | 0.38 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 89–181
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 16 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, REACTOME_OLFACTORY_SIGNALING_PATHWAY, REACTOME_SENSORY_PERCEPTION, GOBP_DETECTION_OF_CHEMICAL_STIMULUS, GOMF_MOLECULAR_TRANSDUCER_ACTIVITY, chr11p11
GO Biological Process (4): signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608), detection of chemical stimulus involved in sensory perception of smell (GO:0050911)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
170 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR4X2 | LNPK | Q9C0E8 | 584 |
| OR4X2 | TBC1D3D | A0A087WVF3 | 573 |
| OR4X2 | C9orf43 | Q8TAL5 | 571 |
| OR4X2 | NALCN | Q8IZF0 | 545 |
| OR4X2 | TBC1D3G | Q6DHY5 | 507 |
| OR4X2 | TBC1D3 | Q8IZP1 | 507 |
| OR4X2 | GEMIN8 | Q9NWZ8 | 506 |
| OR4X2 | ADGRG4 | Q8IZF6 | 488 |
| OR4X2 | SLC6A18 | Q96N87 | 483 |
| OR4X2 | ARSG | Q96EG1 | 480 |
| OR4X2 | GNAL | P38405 | 381 |
| OR4X2 | ANO3 | Q9BYT9 | 376 |
| OR4X2 | THAP1 | Q9NVV9 | 324 |
| OR4X2 | PRKRA | O75569 | 323 |
| OR4X2 | TOR1A | O14656 | 301 |
| OR4X2 | TMTC1 | Q8IUR5 | 301 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| OR4X2 | PCBP3 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (4): MTL5 (Affinity Capture-MS), XAF1 (Affinity Capture-MS), PCBP3 (Affinity Capture-MS), FAM92B (Affinity Capture-MS)
ESM2 similar proteins: A0A096LPK9, A0A0X1KG70, A6NHA9, A6NMZ5, P0C604, P0C623, P0C645, P0DN82, P58180, P58182, Q15615, Q60881, Q6IF82, Q8IXE1, Q8N0Y3, Q8NGA8, Q8NGB4, Q8NGB6, Q8NGC2, Q8NGC3, Q8NGD0, Q8NGD1, Q8NGD2, Q8NGD5, Q8NGE8, Q8NGF4, Q8NGF8, Q8NGF9, Q8NGI4, Q8NGI6, Q8NGJ0, Q8NGJ1, Q8NGL6, Q8NGM1, Q8NGN0, Q8NGN8, Q8NGX5, Q8NH05, Q8NH42, Q8NH49
Diamond homologs: A0A096LPK9, A0A0X1KG70, A6NHA9, A6NMZ5, O60412, O76099, O95013, P0C604, P0C623, P0C645, P0DN82, P23270, P23275, P58173, P58180, P58182, Q15615, Q60878, Q60881, Q60888, Q6IEV9, Q6IEY1, Q6IF82, Q7TQQ0, Q8IXE1, Q8N0Y3, Q8N628, Q8NGA8, Q8NGB2, Q8NGB4, Q8NGB6, Q8NGB8, Q8NGB9, Q8NGC2, Q8NGC3, Q8NGC4, Q8NGC6, Q8NGD0, Q8NGD1, Q8NGD2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
86 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 82 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
109 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:48245347:A:T | donor_gain | 0.8700 |
| 11:48245880:A:AG | acceptor_gain | 0.7400 |
| 11:48245881:G:GG | acceptor_gain | 0.7400 |
| 11:48245346:G:GT | donor_gain | 0.6800 |
| 11:48245833:G:A | acceptor_gain | 0.6800 |
| 11:48245832:T:TA | acceptor_gain | 0.6700 |
| 11:48245494:C:T | donor_gain | 0.6600 |
| 11:48245494:CAGG:C | donor_loss | 0.6500 |
| 11:48245495:AG:A | donor_loss | 0.6500 |
| 11:48245496:GGTG:G | donor_loss | 0.6500 |
| 11:48245497:G:T | donor_loss | 0.6500 |
| 11:48245498:T:G | donor_loss | 0.6500 |
| 11:48245143:G:GT | donor_gain | 0.5700 |
| 11:48245499:GTG:G | donor_loss | 0.5500 |
| 11:48245500:TGT:T | donor_loss | 0.5500 |
| 11:48245492:GGCAG:G | donor_gain | 0.5300 |
| 11:48245493:GCAGG:G | donor_gain | 0.5300 |
| 11:48245777:G:GA | donor_gain | 0.5200 |
| 11:48245881:GACAA:G | acceptor_gain | 0.5000 |
| 11:48245501:G:C | donor_loss | 0.4600 |
| 11:48245776:T:TA | donor_gain | 0.4500 |
| 11:48245775:G:T | donor_gain | 0.4400 |
| 11:48245622:A:AG | acceptor_gain | 0.4300 |
| 11:48245623:G:GG | acceptor_gain | 0.4300 |
| 11:48245493:GCAG:G | donor_gain | 0.4200 |
| 11:48245664:T:A | acceptor_gain | 0.4200 |
| 11:48245779:TGCA:T | donor_gain | 0.4200 |
| 11:48245497:G:GG | donor_gain | 0.4100 |
| 11:48245946:G:GC | acceptor_gain | 0.4000 |
| 11:48245148:GC:G | donor_gain | 0.3800 |
AlphaMissense
1999 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:48245581:T:C | F160L | 0.670 |
| 11:48245583:C:A | F160L | 0.670 |
| 11:48245583:C:G | F160L | 0.670 |
| 11:48245113:T:C | F4L | 0.662 |
| 11:48245115:C:A | F4L | 0.662 |
| 11:48245115:C:G | F4L | 0.662 |
| 11:48245170:T:C | F23L | 0.630 |
| 11:48245172:T:A | F23L | 0.630 |
| 11:48245172:T:G | F23L | 0.630 |
| 11:48245830:T:C | F243L | 0.602 |
| 11:48245832:T:A | F243L | 0.602 |
| 11:48245832:T:G | F243L | 0.602 |
| 11:48245383:T:C | F94L | 0.577 |
| 11:48245385:C:A | F94L | 0.577 |
| 11:48245385:C:G | F94L | 0.577 |
| 11:48245845:T:C | F248L | 0.571 |
| 11:48245847:C:A | F248L | 0.571 |
| 11:48245847:C:G | F248L | 0.571 |
dbSNP variants (sampled 300 via entrez): RS1000870843 (11:48243756 G>C,T), RS1000921729 (11:48243951 A>G), RS1001538798 (11:48245618 A>G), RS1002671628 (11:48243407 T>C), RS1004027926 (11:48246493 C>G), RS1004335311 (11:48244255 C>A,T), RS1005028891 (11:48245522 C>T), RS1005122088 (11:48245269 A>G), RS1006124634 (11:48244174 G>A), RS1006566398 (11:48243138 C>T), RS1007036249 (11:48243235 G>C), RS1007132684 (11:48243118 C>T), RS1007674800 (11:48246092 G>A,T), RS1007687550 (11:48246368 C>A), RS1008223969 (11:48243970 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010774_12 | Essential hypertension (time to event) | 1.000000e-08 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004918 | age at diagnosis |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects cotreatment, decreases methylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Fulvestrant | affects cotreatment, decreases methylation | 1 |
| Silicon Dioxide | increases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): essential hypertension